作者：
Beck,J.T. [1]
;
Hortobagyi,G.N. [2]
;
Campone,M. [3]
;
Lebrun,F. [4]
;
Deleu,I. [5]
;
Rugo,H.S. [6]
;
Pistilli,B. [7]
;
Masuda,N. [8]
;
Hart,L. [9]
;
Melichar,B. [10]
;
Dakhil,S. [11]
;
Geberth,M. [12]
;
Nunzi,M. [13]
;
Heng,D.Y.C. [14]
;
Brechenmacher,T. [15]
;
El-Hashimy,M. [16]
;
Douma,S. [17]
;
Ringeisen,F. ;
Piccart,M.
作者单位：
Tom Baker Cancer Center, University of Calgary, Calgary, AB, Canada
[1]
Ospedale di Macerata, Macerata, Italy
[2]
Palacky University Medical School, Teaching Hospital, Olomouc, Czech Republic
[3]
Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
[4]
Highlands Oncology Group, 3232 N. North Hills Blvd, Fayetteville, AR 72703, United States
[5]
Cancer Center of Kansas, Wichita, KS, United States
[6]
PGO-Mannheim, Schwerpunktpraxis für Gyn?kologische Onkologie, Mannheim, Germany
[7]
Florida Cancer Specialists, Fort Myers, FL, United States
[8]
Novartis Pharma AG, Basel, Switzerland
[9]
Novartis Pharma SAS, Rueil-Malmaison, France
[10]
Hospital Santa Maria of Terni, Terni, Italy
[11]
Institut de Cancérologie de l'Ouest, Rene Gauducheau Centre de Recherche en Cancérologie, Nantes
[12]
Institut Jules Bordet, Brussels, Belgium
[13]
Department of Surgery, Breast Oncology, Osaka National Hospital, Osaka, Japan
[14]
University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San
[15]
University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States
[16]
AZ Nikolaas, Sint-Niklaas, Belgium
[17]
发布时间
2014-05-07
换一批
